Post by AGC Biologics

129,568 followers

šŸ‘ļø š•š¢š¬š¢šØš§ š„šØš¬š¬ šœššš§ šœš”ššš§š šž šžšÆšžš«š²š­š”š¢š§š . š–šžā€™š«šž š°šØš«š¤š¢š§š  š­šØ šœš”ššš§š šž š­š”ššš­. AGC Biologics has expanded our partnership with Novelty Nobility Inc. to advance a first-in-class bispecific antibody for neovascular retinal diseases into GMP manufacturing. From cell line development in Copenhagen to manufacturing in Japan, our global network helps move complex biologics forward, seamlessly. šŸ”— See how this program is progressing to GMP, read the full press release: https://lnkd.in/e6BrcCFS

Post content